Purchase Order 75H71022P00016

Award Date 10/19/21
Potential Completion Date 12/11/24
Potential Value $7.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Irvine, CA 92614, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $23,197.50 firm fixed price purchase order awarded to Central Admixture Pharmacy Services, Inc. (Caps) by the National Institutes of Health (NIH) Clinical Center, a civilian federal agency. The contract is for the provision of compounded sterile pharmaceutical preparations, including total parenteral nutrition (TPN) solutions and other specialized pharmacy services. Caps is an established provider of these products and services, holding several indefinite delivery vehicles (IDVs)...
This is a firm fixed-price delivery order awarded by the Veterans Integrated Service Network 10 (VISN 10) of the Department of Veterans Affairs (VA) to Central Admixture Pharmacy Services, Inc. (Caps), a leading provider of compounded sterile pharmaceutical preparations. The $81,899.74 contract is for the delivery of customized intravenous mixtures, sterile admixtures, total parenteral nutrition (TPN) solutions, and other compounded sterile products to support patient care programs at VA...
This contract was awarded by the Indian Health Service, a civilian federal agency, to Central Admixture Pharmacy Services, Inc. (Caps), a large provider of compounded sterile pharmaceutical preparations. The $81,402.00 firm fixed price contract is for the provision of pharmacy supplies, including intravenous admixtures, total parenteral nutrition solutions, and other compounded sterile products, to support patient care at IHS facilities. The contract has a period of performance from January 1,...
This is a firm-fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) to Central Admixture Pharmacy Services Inc. (Caps), doing business as Caps, for total parenteral nutrition (TPN) services. The contract has a ceiling value of $427,845.58 and an ultimate completion date of September 14, 2023. The contract was awarded under an unrestricted solicitation to provide TPN services, including compounded sterile TPN solutions, to the VA Loma Linda Healthcare System in...
This is a firm fixed price contract awarded by the Defense Health Agency to Central Admixture Pharmacy Services, Inc. (CAPS) for the provision of adult and neonatal total parenteral nutrition. The contract has a potential value of $37,060 and a completion date of September 30, 2023. CAPS is a provider of compounded sterile preparations and pharmacy services to U.S. government agencies, operating both a 503A traditional pharmacy and a 503B outsourcing facility. The company has been awarded over...
This federal contract award, valued at $149,400.00, was issued by the Veterans Integrated Service Network 22 (VISN 22) of the U.S. Department of Veterans Affairs (VA) to Central Admixture Pharmacy Services Inc. (dba Caps), a leading provider of compounded sterile preparations and pharmacy services to government agencies. The award, described as a "VA SD TPN BASE DO", is a firm fixed price delivery order contract for the provision of total parenteral nutrition (TPN) solutions and...
This is a firm fixed price contract awarded by the Defense Health Agency (DHA) to Central Admixture Pharmacy Services Inc., doing business as Caps, for the provision of compounded total parenteral nutrition (TPN) products. The contract has a ceiling value of $250,000.00 and a period of performance ending on August 20, 2025. Caps is a leading provider of specialized pharmacy services, including the production of customized intravenous mixtures, sterile admixtures, and TPN solutions for government...
This is a firm-fixed price purchase order contract awarded by the U.S. Department of Veterans Affairs, Network Contracting Office 8 to Central Admixture Pharmacy Services, Inc. (doing business as Caps) for the delivery of total parenteral nutrition (TPN) intravenous feeding bags. The contract has a ceiling value of $540,629.20 and a period of performance running from October 1, 2024 through September 29, 2029. This contract was awarded on a sole-source basis, as the government determined that...
This is a firm fixed-price contract awarded by the Department of Veterans Affairs (VA) to Central Admixture Pharmacy Services, Inc. (Caps) for the provision of total parenteral nutrition (TPN) and related pharmaceutical supplies. The contract is valued at $66,557.42 and has an ultimate completion date of September 30, 2024. Caps, a large for-profit organization that specializes in compounded sterile pharmaceutical preparations, will deliver these products to the VA Long Beach Healthcare System...
This is a firm fixed price delivery order awarded by the Defense Health Agency (DHA) to Central Admixture Pharmacy Services, Inc. (doing business as Caps), a leading provider of compounded sterile pharmaceutical preparations. The $107,136.00 contract is for the provision of 3,001 sterile admixture caps to support patient care programs at various Department of Defense and other federal healthcare facilities. Caps holds several significant Indefinite Delivery Vehicles (IDVs) with federal agencies,...

This is a firm fixed price purchase order awarded by the Indian Health Service, a civilian agency, to Central Admixture Pharmacy Services, Inc. (Caps) for $7,718.70 to provide pharmacy supplies including sterile admixture services, total parenteral nutrition (TPN) solutions, and other compounded sterile preparations. The period of performance is from January 1, 2022 to December 31, 2022, with an ultimate completion date of December 11, 2024. Caps is a large, established provider of specialized pharmacy services to various U.S. government agencies, including the Department of Veterans Affairs, Defense Health Agency, and National Institutes of Health. The company holds several significant Indefinite Delivery Vehicles with these agencies, allowing for efficient procurement of its compounded pharmaceutical products and services. This specific award does not have a set-aside designation.

Generated 12/12/24, 10:09 AM